Cited by 123Pharmaceutical Practices and Patient OutcomesChronic Disease Management StrategiesPharmacy and Medical Practices

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Medication usage change in older people (65+) in England over 20 years: findings from CFAS I and CFAS II

Open access
Gao, Lu, Maidment, Ian, Matthews, Fiona E, Robinson, Louise, Brayne, Carol, on behalf of the Medical Research Council Cognitive Function and Ageing Study·2018·Age and Ageing

Abstract

Background: medical practice has changed over the last decades reflecting the ageing population, when multi-morbidity requiring multiple medications is more common. Objective: describe and quantify self-reported medicine use including both prescription and over the counter medicines in two comparable population-based studies of older people (65+) in England and to assess the nature and scale of polypharmacy. Methods: data used were from two separate population-based studies; the Cognitive Function Ageing Study I and II. Descriptive analyses were performed to summarise and quantify general medicine use. Negative binomial regression models were fitted to determine factors associated with the number of medicines used. Results: medication use, including both prescribed medicines and over the counter products has increased dramatically over the last 2 decades. The number of people taking five or more items quadrupled from 12 to 49%, while the proportion of people who did not take any medication has decreased from around 1 in 5 to 1 in 13. Cardiovascular drugs were the most frequently taken medication. Polypharmacy is associated with increases in the number of diagnosed long-term conditions. Conclusions: comparison between CFAS I and II reveals marked increases in medication usage and polypharmacy in the older population. The influence of healthcare organisation, introduction of new guidelines and technology changes leading to diagnosis of earlier, milder chronic diseases and treatment may be contributing to this changing pattern. Further research is needed to develop practical solutions to optimise medication management in older people, reducing the harming associated with medication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ageing/afx158

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Middle aged and older populations are increasingly taking multiple drugs, but the potential adverse events of long term use are not well understood.

    “Middle aged and older populations are increasingly taking multiple drugs,6 7 but the potential adverse events of long term use are not well understood.”

    From Anticholinergic drugs and risk of dementia: case-control study (2018) · cites this paper as [6]

    The supplied Results and Discussion passages concern health conditions and functional deficits among people entering care homes, not medication use. Searches for increasing use of multiple drugs and polypharmacy returned the same unrelated passages, so our copy does not verify the claim attributed to this source. The statement about adverse events follows the citations and is not the part judged here. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 18

  1. Bunker, 2001, The role of medical care in contributing to health improvements within societies, Int J Epidemiol, 30, 1260, 10.1093/ije/30.6.1260 · DOI
  2. Francis, 2005, Switching of prescription drugs to over-the-counter status. Is it a good thing for the elderly?, Drugs Aging, 22, 361, 10.2165/00002512-200522050-00001 · DOI
  3. Matthews, 2013, A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II, Lancet, 6736, 4
  4. Guthrie, 2015, The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010, BMC Med, 13, 74, 10.1186/s12916-015-0322-7 · DOI
  5. Franchi, 2014, Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM—Elderly Project 2000–2010, Eur J Clin Pharmacol, 70, 437, 10.1007/s00228-013-1621-6 · DOI
  6. UK D, 2011, Key Statistics on Diabetes
  7. Moynihan, 2012, Preventing overdiagnosis: how to stop harming the healthy, Br Med J, 344, e3502, 10.1136/bmj.e3502 · DOI · Paper page
  8. Nichols, 2013, Cardiovascular disease in Europe: epidemiological update, Eur Heart J, 34, 3028, 10.1093/eurheartj/eht356 · DOI
  9. Hajjar, 2007, Polypharmacy in elderly patients, Am J Geriatr Pharmacother, 5, 345, 10.1016/j.amjopharm.2007.12.002 · DOI
  10. Cahir, 2010, Potentially inappropriate prescribing and cost outcomes for older people: a national population study, Br J Clin Pharmacol, 69, 543, 10.1111/j.1365-2125.2010.03628.x · DOI
  11. Barry, 2016, Potentially inappropriate prescribing among people with dementia in primary care: a retrospective cross-sectional study using the enhanced prescribing database, J Alzheimers Dis, 52, 1503, 10.3233/JAD-151177 · DOI
  12. Parsons, 2010, Withholding, discontinuing, and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?, Drugs Aging, 27, 435, 10.2165/11536760-000000000-00000 · DOI
  13. Spinewine, 2007, Appropriate prescribing in elderly people: how well can it be measured and optimised?, Lancet, 370, 173, 10.1016/S0140-6736(07)61091-5 · DOI
  14. Fox, 2011, Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study, J Am Geriatr Soc, 59, 1477, 10.1111/j.1532-5415.2011.03491.x · DOI · Paper page
  15. Elwyn, 2016, Clinical encounters in the post-guidelines era, Br Med J, 353, i3200, 10.1136/bmj.i3200 · DOI
  16. Scott, 2015, Reducing inappropriate polypharmacy: the process of deprescribing, JAMA Intern Med, 175, 827, 10.1001/jamainternmed.2015.0324 · DOI
  17. Howland, 2009, Medication Holidays, J Psychosoc Nurs Ment Health Serv, 47, 15
  18. Beers, 1997, Explicit criteria for determining potentially inappropriate medication use by the elderly: an update, Arch Intern Med, 10.1001/archinte.1997.00440350031003 · DOI

Cited by

Sorted by citations

Metadata

Authors
Gao, L., Maidment, I., Matthews, F. E., Robinson, L., Brayne, C., & on behalf of the Medical Research Council Cognitive Function and Ageing Study
Affiliations
  • MRC Biostatistics Unit (GB)
  • Aston University (GB)
  • Newcastle University (GB)
  • University of Cambridge (GB)
Corresponding author
Brayne, Carol
Venue
Age and Ageing
Published
2017-09-26
Volume
47
Issue
2
Pages
220-225
ISSN
  • 0002-0729 (ISSN-L)
  • 1468-2834
OpenAlex
W2763066659
Cited by
123
References
2
Citations by year
2026: 12 · 2025: 11 · 2024: 14 · 2023: 18 · 2022: 16 · 2021: 17 · 2020: 18 · 2019: 9 · 2018: 6 · 2017: 2
FWCI
8.01
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Age and Ageing (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion, cc-by)
  • PubMed Central (acceptedVersion, cc-by)
  • Aston Publications Explorer (Aston University) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
  • Repository@Hull (Worktribe) (University of Hull) (submittedVersion)
  • Apollo
Funders
  • Department of Health
  • Medical Research Council
  • The National Institute of Health Research (G9901400, G0601022)
  • MRC (U105292687)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
  • Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
Keywords
medication use, polypharmacy, older adults, over-the-counter drugs, prescription drugs, chronic disease, cardiovascular drugs, temporal trends, medication management
MeSH terms
Age Factors, Aged, Drug Therapy, Nonprescription Drugs, England, Geriatrics, Health Status, Humans, Longitudinal Studies, Practice Patterns, Physicians', Drug Prescriptions, State Medicine, Time Factors, Polypharmacy, Prescription Drugs, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review